Solicitation of Nominations for Organizational Representatives to the Advisory Committee on Heritable Disorders in Newborns and Children, 65354-65356 [2018-27518]
Download as PDF
<![CDATA[
65354
Federal Register / Vol. 83, No. 244 / Thursday, December 20, 2018 / Notices
Board of Governors of the Federal Reserve
System, December 17, 2018.
Yao-Chin Chao,
Assistant Secretary of the Board.
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
[FR Doc. 2018–27575 Filed 12–19–18; 8:45 am]
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the offices of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than January
7, 2019.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. Edward J. Madden, Evanston,
Illinois, individually and as trustee of
the Edward J. Madden Declaration of
Trust 3/6/2008; to join the Madden
Family Group and to acquire voting
shares of Schaumburg Bancshares, Inc.,
and thereby indirectly acquire shares of
Heritage Bank of Schaumburg, both of
Schaumburg, Illinois.
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; ACF’s Generic Clearance for
Grant Reviewer Recruitment Forms
(OMB #0970–0477)
Office of Planning, Research,
and Evaluation; Administration for
Children and Families; HHS.
ACTION: Request for public comment.
AGENCY:
The Administration for
Children and Families (ACF), Office of
Planning, Research, and Evaluation
(OPRE) is proposing an extension of a
currently approved generic clearance
(OMB no. 0970–0477) for Grant
Reviewer Recruitment (GRR) forms. The
GRR forms will be used to select
reviewers who will participate in the
grant review process for the purpose of
selecting successful applications.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
the Administration for Children and
Families is soliciting public comment
SUMMARY:
on the specific aspects of the
information collection described above.
ADDRESSES: Copies of the proposed
collection of information can be
obtained and comments may be
forwarded by writing to the
Administration for Children and
Families, Office of Planning, Research,
and Evaluation, 330 C Street SW,
Washington, DC 20201, Attn: OPRE
Reports Clearance Officer. Email
address: OPREinfocollection@
acf.hhs.gov. All requests should be
identified by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: Under this generic
approval, ACF conducts and proposes to
continue to conduct more than one
information collection that is very
similar, voluntary, low-burden and
uncontroversial. The purpose is to select
qualified reviewers for the grant peer
review process based on professional
qualifications using data entered by
candidates and the uploaded writing
sample and/or curriculum vitae and/or
resume. The grant review process is in
accordance with the U.S. Department of
Health and Human Services’ (DHHS)
Grants Policy Directive (GPD) 2.04
‘‘Awarding Grants’’, the DHHS
Awarding Agency Grants
Administration Manual (AAGAM),
Chapter 2.04.104C ‘‘Objective Review of
Grant Applications’’, and the Public
Health Service (PHS) Act, Sections
799(f) and 806(e).
Respondents: Individuals who may
apply to review ACF grant applications.
khammond on DSK30JT082PROD with NOTICES
ANNUAL BURDEN ESTIMATES
Instrument
Total number
of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Annual burden
hours
Grant Reviewer Recruitment Form ..................................................................
3000
1
.5
1500
Estimated Total Annual Burden
Hours: 1500.
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
VerDate Sep<11>2014
17:21 Dec 19, 2018
Jkt 247001
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2018–27551 Filed 12–19–18; 8:45 am]
BILLING CODE 4184–79–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Solicitation of Nominations for
Organizational Representatives to the
Advisory Committee on Heritable
Disorders in Newborns and Children
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Request for nominations.
AGENCY:
HRSA is seeking nominations
from organizations to send a
representative to be a liaison to the
SUMMARY:
Frm 00018
Fmt 4703
Sfmt 4703
E:\FR\FM\20DEN1.SGM
20DEN1
khammond on DSK30JT082PROD with NOTICES
Federal Register / Vol. 83, No. 244 / Thursday, December 20, 2018 / Notices
Advisory Committee on Heritable
Disorders in Newborns and Children
(Committee). Selections will be based
on a review of the organization’s subject
area of expertise, mission, relevancy,
and benefit provided relative to the
Committee’s purpose. The
organizational representatives are nonvoting liaisons. The Committee provides
advice, recommendations, and technical
information about aspects of heritable
disorders and newborn and childhood
screening to the Secretary of HHS.
HRSA is seeking nominations of
qualified organizations to fill up to three
positions.
Authority: Section 1111 of the Public
Health Service (PHS) Act, as amended
by the Newborn Screening Saves Lives
Reauthorization Act of 2014 (42 U.S.C.
300b–10). The Committee is governed
by the Federal Advisory Committee Act
(FACA), as amended (5 U.S.C. App.),
and 41 CFR part 102–3, which set forth
standards for the formation and use of
advisory committees.
DATES: Written nominations for
organization representatives on the
Committee must be received on or
before January 17, 2019.
ADDRESSES: Nomination packages must
be submitted electronically as email
attachments to Catharine Riley, Ph.D.,
MPH, Genetic Services Branch,
Maternal and Child Health Bureau,
HRSA, criley@hrsa.gov.
FOR FURTHER INFORMATION CONTACT:
Designated Federal Official (DFO)
Catharine Riley, Ph.D., MPH. Address:
MCHB, HRSA 5600 Fishers Lane, Room
18–W–68, Rockville, MD 20857; phone
number: 301–443–1291; email: criley@
hrsa.gov. A copy of the Committee
Charter and list of the current
membership can be obtained by
accessing the Advisory Committee
website at: www.hrsa.gov/advisorycommittees/heritable-disorders.
SUPPLEMENTARY INFORMATION: The
Committee is chartered under section
1111 of the PHS Act, as amended by the
Newborn Screening Saves Lives
Reauthorization Act of 2014 (42 U.S.C.
300b–10). The Committee was
established in 2003 to advise the
Secretary of HHS regarding newborn
screening tests, technologies, policies,
guidelines, and programs for effectively
reducing morbidity and mortality in
newborns and children having or at risk
for heritable disorders. In addition, the
Committee provides advice and
recommendations to the Secretary
concerning the grants and projects
authorized under section 1109 of the
PHS Act and technical information to
develop policies and priorities for
grants, including those that will
VerDate Sep<11>2014
17:21 Dec 19, 2018
Jkt 247001
enhance the ability of the state and local
health agencies to provide for newborn
and child screening, counseling and
health care services for newborns, and
children having or at risk for heritable
disorders. The Committee also is
governed by the provisions of FACA, as
amended (5 U.S.C. App. 2), and 41 CFR
part 102–3, which set forth standards for
the formation and use of advisory
committees.
The Committee reviews and reports
regularly on newborn and childhood
screening practices for heritable
disorders, recommends improvements
in the national newborn and childhood
heritable screening programs, and
recommends conditions for inclusion in
the Recommended Uniform Screening
Panel (RUSP). The Committee’s
recommendations regarding additional
conditions/inherited disorders for
screening that have been adopted by the
Secretary of HHS are included in the
RUSP and constitute part of the
comprehensive guidelines supported by
HRSA pursuant to section 2713 of the
PHS Act, codified at 42 U.S.C. 300gg–
13. Under this provision, nongrandfathered health plans and group
and individual health insurance issuers
are required to cover screenings
included in the HRSA-supported
comprehensive guidelines without
charging a co-payment, co-insurance, or
deductible for plan years (i.e., in the
individual market, policy years)
beginning on or after the date that is 1
year from the Secretary’s adoption of the
condition for screening.
Nominations: The Committee may
invite up to 15 organizations to
designate individuals to serve as nonvoting liaisons. Organizations should
demonstrate wide-ranging newborn
screening and heritable disorders
interests. In addition, the organization’s
work should inform the activities of the
Committee. Eligible organizations must
represent national public health
constituencies, medical professional
societies, or organizations with large,
broad constituencies and broad interest
or involvement in newborn screening.
Organizations which represent narrow
interests (e.g., interest in a single disease
or treatment) or smaller constituencies
are not eligible. Organizational
representatives attend Committee
meetings to provide relevant expertise
and perspectives to Committee members
during their deliberations and
discussions, but they do not vote and
are not considered official members of
the Committee.
Applications must contain a cover
letter and statement. The cover letter
should include: Organization name and
mission statement; contact information
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
65355
for the designated representative,
including point of contact name,
address, email, telephone number; and
website of the organization. The
statement should include: Perspective
and expertise provided by the
organization and its relevance to the
Committee; a description of how the
Committee’s work affects and impacts
the organization and its constituency; a
list of organizational projects, programs,
and products that are of relevance to the
Committee’s work; an affirmation of the
organization’s commitment to identify a
representative with expertise who can
attend Committee meetings in person
and provide input to the Committee, at
the discretion of the Chairperson; an
affirmation of the organization’s
commitment to financially support (e.g.,
cover travel expenses) a representative
to attend committee meetings held in
Rockville, MD; an affirmation of the
organization’s commitment to ensure
active contribution to and dissemination
of Committee activities and
recommendations to its constituencies;
affirmation the designated
representative is able to serve as the
liaison; and an affirmation that the
organization has no conflict of interest
that would preclude informing the
Committee in a fair and balanced
manner. If there are potential conflicts
of interest, please detail the information
concerning any possible conflicts of
interest relative to both the organization
and the proposed organizational
representative (e.g., current or
anticipated employment, consultancies,
research grants, or contracts), as well as
how the organization proposes to
address the potential conflict.
Organizations are eligible to send a
representative as long as the
organization’s subject area of expertise
and mission is relevant to the
Committee’s purpose, objective, scope
of activities and duties, and as long as
the organization actively participates on
Committee activities. Every three years,
the Chair and DFO will re-assess the
organization’s mission, relevancy, and
benefit as it relates to the Committee’s
purpose, objective, scope of activities,
and duties. Every three years current
organizations will be asked to reaffirm
their commitment to send an
organizational representative.
The selection of eligible organizations
is based on a review of the
organization’s subject area of expertise,
mission, relevancy, and benefit as it
relates to the Committee’s purpose. The
Committee Charter, legislation, and list
of current voting membership may be
obtained by accessing the Committee
website at https://www.hrsa.gov/
advisory-committees/heritable-
E:\FR\FM\20DEN1.SGM
20DEN1
65356
Federal Register / Vol. 83, No. 244 / Thursday, December 20, 2018 / Notices
disorders. Final selection of
organizational representatives will be
made by the Committee Chair and
HRSA.
Amy P. McNulty,
Acting Director, Division of the Executive
Secretariat.
[FR Doc. 2018–27518 Filed 12–19–18; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–7003–N–01]
60-Day Notice of Proposed Information
Collection: Comment Request;
Housing Discrimination Information
Form; HUD–903.1, HUD–903.1A, HUD–
903.1B, HUD–903.1C, HUD–903.1F,
HUD–903.1CAM, HUD–903.1KOR,
HUD–903.1RUS, HUD–903–1_Somali
Office of the Assistant
Secretary for Fair Housing and Equal
Opportunity, HUD.
ACTION: Notice.
AGENCY:
The proposed reinstatement,
without change, of a previously
approved information collection for
Housing Discrimination Information
Form HUD–903.1, HUD–903.1A, HUD–
903.1B, HUD–903.1C, HUD–903.1F,
HUD–903.1CAM, HUD–903.1KOR,
HUD–903.1RUS, and HUD–903–1_
Somali will be submitted to the Office
of Management and Budget (OMB) for
review, in accordance with the
Paperwork Reduction Act of 1995. HUD
is soliciting comments from all
interested parties on the proposed
extension of this information collection.
DATES: Comment Due Date: February 19,
2019.
ADDRESSES: Interested persons are
invited to submit comments regarding
this proposed information collection.
Comments should refer to the proposal
by name and/or OMB Control Number,
and should be sent to Inez C. Downs,
Departmental Paperwork Reduction Act
Officer, QMAC, U.S. Department of
Housing and Urban Development, 451
7th Street SW, Room 4186, Washington,
DC 20410–2000; telephone number
(202) 402–8046 (this is not a toll-free
number), or email at Inez.C.Downs@
hud.gov for a copy of the proposed
forms or other available information; or
to Colette Pollard, Departmental
Paperwork Reduction Officer, QMAC,
U.S. Department of Housing and Urban
Development, 451 7th Street SW, Room
4186, Washington, DC 20410–2000;
telephone number (202) 402–3400 (this
is not a toll-free number), or email at
khammond on DSK30JT082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:21 Dec 19, 2018
Jkt 247001
Colette.Pollard@hud.gov for a copy of
the proposed forms or other available
information. Hearing or speech
impaired individuals may access both
numbers via TTY by calling the toll-free
Federal Relay Service at: 1–(800) 877–
8339;
FOR FURTHER INFORMATION CONTACT:
Gordon F. Patterson, Department of
Housing and Urban Development, 451
7th Street SW, Room 5214, Washington,
DC 20410–2000; telephone number
(202) 402–3264 (this is not a toll-free
number). Hearing or speech impaired
individuals may access this number via
TTY by calling the toll-free Federal
Relay Service at: 1–(800) 877–8339.
SUPPLEMENTARY INFORMATION: HUD is
submitting this proposed extension of a
currently approved information
collection to the OMB for review, as
required by the Paperwork Reduction
Act of 1995 [44 U.S.C. Chapter 35, as
amended].
A. Overview of Information Collection
This Notice is soliciting comments
from members of the public and affected
agencies concerning the proposed
reinstatement, without change, of a
previously approved collection of
information regarding alleged
discriminatory housing practices under
the Fair Housing Act [42 U.S.C. 3601 et
seq.]. The Fair Housing Act prohibits
discrimination in the sale, rental,
occupancy, advertising, and insuring of
residential dwellings; and in residential
real estate-related transactions; and in
the provision of brokerage services,
based on race, color, religion, sex,
handicap [disability], familial status, or
national origin.
Any person who claims to have been
injured by a discriminatory housing
practice, or who believes that he or she
will be injured by a discriminatory
housing practice that is about to occur,
may file a complaint with HUD not later
than one year after the alleged
discriminatory housing practice
occurred or terminated. HUD has
designed Housing Discrimination
Information Form HUD–903.1 to
promote consistency in the documents
that, by statute, must be provided to
persons against whom complaints are
filed, and for the convenience of the
general public. Section 103.25 of HUD’s
Fair Housing Act regulation describes
the information that must be included
in each complaint filed with HUD. For
purposes of meeting the Act’s one-year
time limitation for filing complaints
with HUD, complaints need not be
initially submitted on the Form that
HUD provides. Housing Discrimination
Information Form HUD–903.1 (English
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
language), HUD–903.1A (Spanish
language), HUD–903.1B (Chinese
language), HUD–903.1C (Arabic
language), HUD–903.1F (Vietnamese
language), HUD–903.1CAM (Cambodian
language), HUD–903.1KOR (Korean
language), HUD–903.1RUS (Russian
language), and HUD–903–1_(Somali
language) may be submitted to HUD by
mail, in person, by facsimile, by email,
or via the internet to HUD’s Office of
Fair Housing and Equal Opportunity
(FHEO). FHEO staff uses the
information provided on the Form to
verify HUD’s authority to investigate the
aggrieved person’s allegations under the
Fair Housing Act.
Title of Information Collection:
Housing Discrimination Information
Form.
OMB Control Number: 2529–0011.
Type of Request: Proposed
reinstatement, without change, of a
previously approved information
collection.
Form Number: HUD–903.1.
Description of the need for the
information and proposed use: HUD
uses the Housing Discrimination
Information Form HUD–903.1 (Form) to
collect pertinent information from
persons wishing to file housing
discrimination complaints with HUD
under the Fair Housing Act. The Fair
Housing Act makes it unlawful to
discriminate in the sale, rental,
occupancy, advertising, or insuring of
residential dwellings; or to discriminate
in residential real estate-related
transactions; or in the provision of
brokerage services, based on race, color,
religion, sex, handicap [disability],
familial status, or national origin.
Any person who claims to have been
injured by a discriminatory housing
practice, or any person who believes
that he or she will be injured by a
discriminatory housing practice that is
about to occur, may file a complaint
with HUD not later than one year after
the alleged discriminatory housing
practice occurs or terminates. The Form
promotes consistency in the collection
of information necessary to contact
persons who file housing discrimination
complaints with HUD. It also aids in the
collection of information necessary for
initial assessments of HUD’s authority
to investigate alleged discriminatory
housing practices under the Fair
Housing Act. This information may
subsequently be provided to persons
against whom complaints are filed
[‘‘respondents’’], as required under
section 810(a)(1)(B)(ii) of the Fair
Housing Act.
Agency form numbers, if applicable:
Form HUD–903.1 (English), Form HUD–
903.1A (Spanish), Form HUD–903.1B
E:\FR\FM\20DEN1.SGM
20DEN1
]]>Agencies
[Federal Register Volume 83, Number 244 (Thursday, December 20, 2018)]
[Notices]
[Pages 65354-65356]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-27518]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Solicitation of Nominations for Organizational Representatives to
the Advisory Committee on Heritable Disorders in Newborns and Children
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Request for nominations.
-----------------------------------------------------------------------
SUMMARY: HRSA is seeking nominations from organizations to send a
representative to be a liaison to the
[[Page 65355]]
Advisory Committee on Heritable Disorders in Newborns and Children
(Committee). Selections will be based on a review of the organization's
subject area of expertise, mission, relevancy, and benefit provided
relative to the Committee's purpose. The organizational representatives
are non-voting liaisons. The Committee provides advice,
recommendations, and technical information about aspects of heritable
disorders and newborn and childhood screening to the Secretary of HHS.
HRSA is seeking nominations of qualified organizations to fill up to
three positions.
Authority: Section 1111 of the Public Health Service (PHS) Act, as
amended by the Newborn Screening Saves Lives Reauthorization Act of
2014 (42 U.S.C. 300b-10). The Committee is governed by the Federal
Advisory Committee Act (FACA), as amended (5 U.S.C. App.), and 41 CFR
part 102-3, which set forth standards for the formation and use of
advisory committees.
DATES: Written nominations for organization representatives on the
Committee must be received on or before January 17, 2019.
ADDRESSES: Nomination packages must be submitted electronically as
email attachments to Catharine Riley, Ph.D., MPH, Genetic Services
Branch, Maternal and Child Health Bureau, HRSA, criley@hrsa.gov.
FOR FURTHER INFORMATION CONTACT: Designated Federal Official (DFO)
Catharine Riley, Ph.D., MPH. Address: MCHB, HRSA 5600 Fishers Lane,
Room 18-W-68, Rockville, MD 20857; phone number: 301-443-1291; email:
criley@hrsa.gov. A copy of the Committee Charter and list of the
current membership can be obtained by accessing the Advisory Committee
website at: www.hrsa.gov/advisory-committees/heritable-disorders.
SUPPLEMENTARY INFORMATION: The Committee is chartered under section
1111 of the PHS Act, as amended by the Newborn Screening Saves Lives
Reauthorization Act of 2014 (42 U.S.C. 300b-10). The Committee was
established in 2003 to advise the Secretary of HHS regarding newborn
screening tests, technologies, policies, guidelines, and programs for
effectively reducing morbidity and mortality in newborns and children
having or at risk for heritable disorders. In addition, the Committee
provides advice and recommendations to the Secretary concerning the
grants and projects authorized under section 1109 of the PHS Act and
technical information to develop policies and priorities for grants,
including those that will enhance the ability of the state and local
health agencies to provide for newborn and child screening, counseling
and health care services for newborns, and children having or at risk
for heritable disorders. The Committee also is governed by the
provisions of FACA, as amended (5 U.S.C. App. 2), and 41 CFR part 102-
3, which set forth standards for the formation and use of advisory
committees.
The Committee reviews and reports regularly on newborn and
childhood screening practices for heritable disorders, recommends
improvements in the national newborn and childhood heritable screening
programs, and recommends conditions for inclusion in the Recommended
Uniform Screening Panel (RUSP). The Committee's recommendations
regarding additional conditions/inherited disorders for screening that
have been adopted by the Secretary of HHS are included in the RUSP and
constitute part of the comprehensive guidelines supported by HRSA
pursuant to section 2713 of the PHS Act, codified at 42 U.S.C. 300gg-
13. Under this provision, non-grandfathered health plans and group and
individual health insurance issuers are required to cover screenings
included in the HRSA-supported comprehensive guidelines without
charging a co-payment, co-insurance, or deductible for plan years
(i.e., in the individual market, policy years) beginning on or after
the date that is 1 year from the Secretary's adoption of the condition
for screening.
Nominations: The Committee may invite up to 15 organizations to
designate individuals to serve as non-voting liaisons. Organizations
should demonstrate wide-ranging newborn screening and heritable
disorders interests. In addition, the organization's work should inform
the activities of the Committee. Eligible organizations must represent
national public health constituencies, medical professional societies,
or organizations with large, broad constituencies and broad interest or
involvement in newborn screening. Organizations which represent narrow
interests (e.g., interest in a single disease or treatment) or smaller
constituencies are not eligible. Organizational representatives attend
Committee meetings to provide relevant expertise and perspectives to
Committee members during their deliberations and discussions, but they
do not vote and are not considered official members of the Committee.
Applications must contain a cover letter and statement. The cover
letter should include: Organization name and mission statement; contact
information for the designated representative, including point of
contact name, address, email, telephone number; and website of the
organization. The statement should include: Perspective and expertise
provided by the organization and its relevance to the Committee; a
description of how the Committee's work affects and impacts the
organization and its constituency; a list of organizational projects,
programs, and products that are of relevance to the Committee's work;
an affirmation of the organization's commitment to identify a
representative with expertise who can attend Committee meetings in
person and provide input to the Committee, at the discretion of the
Chairperson; an affirmation of the organization's commitment to
financially support (e.g., cover travel expenses) a representative to
attend committee meetings held in Rockville, MD; an affirmation of the
organization's commitment to ensure active contribution to and
dissemination of Committee activities and recommendations to its
constituencies; affirmation the designated representative is able to
serve as the liaison; and an affirmation that the organization has no
conflict of interest that would preclude informing the Committee in a
fair and balanced manner. If there are potential conflicts of interest,
please detail the information concerning any possible conflicts of
interest relative to both the organization and the proposed
organizational representative (e.g., current or anticipated employment,
consultancies, research grants, or contracts), as well as how the
organization proposes to address the potential conflict.
Organizations are eligible to send a representative as long as the
organization's subject area of expertise and mission is relevant to the
Committee's purpose, objective, scope of activities and duties, and as
long as the organization actively participates on Committee activities.
Every three years, the Chair and DFO will re-assess the organization's
mission, relevancy, and benefit as it relates to the Committee's
purpose, objective, scope of activities, and duties. Every three years
current organizations will be asked to reaffirm their commitment to
send an organizational representative.
The selection of eligible organizations is based on a review of the
organization's subject area of expertise, mission, relevancy, and
benefit as it relates to the Committee's purpose. The Committee
Charter, legislation, and list of current voting membership may be
obtained by accessing the Committee website at https://www.hrsa.gov/
advisory-committees/heritable-
[[Page 65356]]
disorders. Final selection of organizational representatives will be
made by the Committee Chair and HRSA.
Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-27518 Filed 12-19-18; 8:45 am]
BILLING CODE 4165-15-P
